Mazzanti A, Kevin Ng, Alessandro Faragli, et al. Arrhythmogenic right ventricular cardiomyopathy:Clinical course and predictors of arrhythmic risk. J Am Coll Cardiol 2016; in press.
Sroubek J, Probst V, Mazzanti A, et al. Programmed Ventricular Stimulation for Risk Stratification in the Brugada Syndrome: A Pooled Analysis. Circulation 2016;133(7):622-30.
Mazzanti A, Maragna R, Faragli A, et al. Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3. J Am Coll Cardiol 2016;67(9):10538.
Curcio A, Mazzanti A, Bloise R, et al. J Cardiovasc Electrophysiol 2016 doi: 10.1111/jce.12997.
Mazzanti A, Priori S. Brugada Syndrome: The Endless Conundrum. J Am Coll Cardiol 2016; in press.
Priori SG, Blomstrom-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2015;36(41):2793-867.
Mazzanti A, O'Rourke S, Ng K, et al. The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases. Expert Rev Cardiovasc Ther 2014;12(4):499-519.
Mazzanti A, Kanthan A, Monteforte N, et al. Novel insight into the natural history of short QT syndrome. J Am Coll Cardiol 2014;63(13):1300-8.
Mazzanti A, Priori SG. Molecular autopsy for sudden unexplained death? Time to discuss pros and cons. J Cardiovasc Electrophysiol 2012;23(10):1099-102.
Giustetto C, Schimpf R, Mazzanti A, et al. Long-term follow-up of patients with short QT syndrome. J Am Coll Cardiol 2011;58(6):587-95.
